DMG-PEG2000-NH2: A Benchmark Polyethylene Glycol Amine Linker for Lipid Nanoparticle Formulation

Executive Summary: DMG-PEG2000-NH2 (SKU M2006) is a primary amine-terminated polyethylene glycol derivative designed for amide bond formation in lipid-based drug delivery and bioconjugation workflows (APExBIO). The product exhibits high purity (>90%) and excellent solubility in DMSO (≥51.6 mg/mL), ethanol (≥52 mg/mL), and water (≥25.3 mg/mL) at room temperature. Its molecular weight is 2528 Da, and storage at -20°C is recommended to maintain integrity. DMG-PEG2000-NH2 enhances the stability, solubility, and biocompatibility of conjugated biomolecules, providing reproducibility in lipid nanoparticle (LNP) and liposomal formulations (see cell-based assay impact). This article summarizes the biological rationale, mechanism, and evidence underpinning its application in advanced drug delivery and pharmaceutical research.

Biological Rationale

Polyethylene glycol (PEG) derivatives functionalized with primary amines are essential tools in bioconjugation and drug delivery. DMG-PEG2000-NH2 serves as a versatile linker, connecting carboxyl-containing biomolecules to lipid-based carriers via amide bond formation. This approach is used in constructing lipid nanoparticles (LNPs) and liposomes for encapsulating nucleic acids (e.g., siRNA), peptides, and proteins. PEGylation enhances solubility, circulation time, and biocompatibility of therapeutic agents, reducing rapid clearance and immunogenicity (APExBIO product page). The primary amine group on DMG-PEG2000-NH2 reacts efficiently with activated carboxylic acids under mild conditions, supporting controlled conjugation in aqueous or organic media. The molecular weight of 2528 Da provides a balance between stealth properties and functionalization efficiency. PEGylated lipids, such as DMG-PEG2000-NH2, are widely adopted in siRNA delivery platforms and next-generation antibiotics, facilitating improved pharmacokinetics and reduced cytotoxicity (see mechanistic deep dive).

Mechanism of Action of DMG-PEG2000-NH2

DMG-PEG2000-NH2 acts as a bifunctional linker with a dimyristoyl glycerol (DMG) hydrophobic anchor and a PEG2000 chain terminated by a primary amine (-NH2). The DMG moiety embeds within lipid bilayers, ensuring stable incorporation into liposomes or LNPs. The hydrophilic PEG2000 segment extends into the aqueous phase, imparting steric stabilization and minimizing aggregation. The terminal NH2 group undergoes nucleophilic attack on activated carboxyl groups (e.g., NHS esters) to form stable amide bonds. This chemistry is compatible with mild, aqueous or organic solvent conditions and preserves biomolecule function (Chen et al., 2021). The PEGylation reduces nonspecific protein binding and opsonization, thereby increasing circulation time and delivery efficiency. In LNP workflows, DMG-PEG2000-NH2 enables post-insertion or co-formulation strategies, permitting modular design and functionalization of the nanoparticle surface (benchmarking article).

Evidence & Benchmarks

• DMG-PEG2000-NH2 achieves solubility of ≥51.6 mg/mL in DMSO, ≥52 mg/mL in ethanol, and ≥25.3 mg/mL in water at 20–25°C (APExBIO product documentation).
• The primary amine enables efficient amide bond formation with carboxylated biomolecules in aqueous buffer, pH 7.4–8.5, at 20–25°C, yielding >90% conjugation efficiency in validated protocols (mechanistic insights).
• PEGylated LNPs incorporating DMG-PEG2000-NH2 demonstrate enhanced colloidal stability and reduced aggregation relative to non-PEGylated controls in serum-containing media (Chen et al., 2021).
• Lipid nanoparticles using DMG-PEG2000-NH2 show reproducible siRNA encapsulation rates exceeding 80% (measured by RiboGreen assay, 25°C, pH 7.5, 1 h incubation) (mechanistic deep dive).
• Storage at -20°C preserves DMG-PEG2000-NH2 integrity for ≥12 months; prolonged storage of solutions at room temperature leads to hydrolysis and activity loss (APExBIO COA/MSDS).

Applications, Limits & Misconceptions

DMG-PEG2000-NH2 is applied in LNP and liposome construction for drug and gene delivery, as well as in bioconjugation of proteins, peptides, and small molecules. Its primary amine group allows site-specific attachment to carboxylated targets, supporting the development of antibody-drug conjugates, diagnostic reagents, and cell-surface modifications. The product supports workflows in cell viability, proliferation, and cytotoxicity assays, with documented impact on conjugation efficiency and reproducibility (related article—this article updates with advanced formulation parameters and stability data).

Common Pitfalls or Misconceptions

• DMG-PEG2000-NH2 is not suitable for direct use with unactivated carboxyl groups; activation (e.g., NHS, EDC chemistry) is required for amide bond formation.
• This linker is not designed for covalent attachment to thiol, aldehyde, or azide groups—other functionalized PEGs are needed for those chemistries.
• Long-term storage of DMG-PEG2000-NH2 solutions at room temperature leads to hydrolysis and reduced activity; always store solid at -20°C and prepare solutions fresh.
• The product is not a therapeutic agent itself and should not be used in final drug formulations without comprehensive toxicological evaluation.
• High concentrations (>100 mg/mL) may exceed solubility limits in some aqueous buffers; always verify dissolution before use.

Workflow Integration & Parameters

For bioconjugation, dissolve DMG-PEG2000-NH2 in DMSO, ethanol, or water at desired concentration (typically 1–50 mg/mL). Use freshly prepared solutions for optimal reactivity. For amide coupling, activate carboxyl-containing partners with NHS/EDC in pH 7.4–8.5 buffer, then add DMG-PEG2000-NH2 and incubate 1–2 hours at room temperature. In LNP or liposome formulation, co-dissolve with lipids in organic solvent, dry to film, and hydrate in buffer. Alternatively, use post-insertion into pre-formed vesicles at 37°C for 30–60 minutes. Validate encapsulation and conjugation efficiency using colorimetric, fluorometric, or chromatographic assays. For cell-based assays, confirm lack of cytotoxicity at working concentrations using standard viability protocols (evidence-based guidance—this article provides updated QC and storage guidance).

Conclusion & Outlook

DMG-PEG2000-NH2 is a validated bioconjugation reagent and PEGylated lipid for constructing advanced LNP and liposomal platforms. Its high-purity, defined solubility, and robust amide coupling reactivity support reproducible drug delivery workflows. Ongoing research continues to optimize PEG linker length, density, and surface presentation for next-generation therapeutics (Chen et al., 2021). As a product from APExBIO, DMG-PEG2000-NH2 offers quality assurance and detailed documentation for translational researchers. For further mechanistic detail and workflow scenarios, see related reviews (mechanistic insights—this article details recent quantitative benchmarks and storage recommendations not included in the cited review).